Joseph Buriak

Statistics

Publications

Citations

H-Index

Active since

1999

Affiliations

Bristol-Myers Squibb (United States)(Current)

Joseph Buriak is an author at Bristol-Myers Squibb (United States) specializing in synthetic medicinal chemistry, enzyme inhibition, and anticoagulant pharmacology.

Publications per year

1999–2006

Publications

Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor Xa

John M. Fevig, Joseph Cacciola, Joseph Buriak et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa

Yunlong Li, John M. Fevig, Joseph Cacciola et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 31 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Preparation of pyrrolidine and isoxazolidine benzamidines as potent inhibitors of coagulation factor Xa

John M. Fevig, Joseph Buriak, Pieter F. W. Stouten et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 12 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–3 of 3